[go: up one dir, main page]

MX2009007384A - Formulaciones que contienen ?-lactama con elevada estabilidad en disolucion acuosa. - Google Patents

Formulaciones que contienen ?-lactama con elevada estabilidad en disolucion acuosa.

Info

Publication number
MX2009007384A
MX2009007384A MX2009007384A MX2009007384A MX2009007384A MX 2009007384 A MX2009007384 A MX 2009007384A MX 2009007384 A MX2009007384 A MX 2009007384A MX 2009007384 A MX2009007384 A MX 2009007384A MX 2009007384 A MX2009007384 A MX 2009007384A
Authority
MX
Mexico
Prior art keywords
lactam
aqueous solution
increased stability
containing formulations
formulations
Prior art date
Application number
MX2009007384A
Other languages
English (en)
Inventor
Dirk Mertin
Bernd Bigalke
Franz Pirro
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of MX2009007384A publication Critical patent/MX2009007384A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

La invención se refiere a nuevas formulaciones para disolver en agua que contienen un antibiótico 3-lactámico y urea y cuyo valor de pH después de disolver la formulación en agua se encuentra en el intervalo de 4,5 a 8. Las formulaciones son especialmente adecuadas para el tratamiento de animales contra enfermedades bacterianas.
MX2009007384A 2007-01-19 2008-01-10 Formulaciones que contienen ?-lactama con elevada estabilidad en disolucion acuosa. MX2009007384A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007002924A DE102007002924A1 (de) 2007-01-19 2007-01-19 ß-Lactam-haltige Formulierungen mit erhöhter Stabilität in wässriger Lösung
PCT/EP2008/000125 WO2008086971A2 (de) 2007-01-19 2008-01-10 β-LACTAM-HALTIGE FORMULIERUNGEN MIT ERHÖHTER STABILITÄT IN WÄSSRIGER LÖSUNG

Publications (1)

Publication Number Publication Date
MX2009007384A true MX2009007384A (es) 2009-08-13

Family

ID=39530785

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009007384A MX2009007384A (es) 2007-01-19 2008-01-10 Formulaciones que contienen ?-lactama con elevada estabilidad en disolucion acuosa.

Country Status (6)

Country Link
US (1) US20100035856A1 (es)
EP (1) EP2124887A2 (es)
BR (1) BRPI0806900A2 (es)
DE (1) DE102007002924A1 (es)
MX (1) MX2009007384A (es)
WO (1) WO2008086971A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011078830A1 (en) * 2009-12-25 2011-06-30 Bilgic Mahmut Rapidly dispersing effervescent formulation
US8614315B2 (en) 2009-12-25 2013-12-24 Mahmut Bilgic Cefdinir and cefixime formulations and uses thereof
TR200909785A1 (tr) * 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
WO2011139252A2 (en) * 2010-05-04 2011-11-10 Mahmut Bilgic Efervescent formulations comprising cefdinir
DE102014012022A1 (de) * 2014-08-13 2016-02-18 Clariant International Ltd. Organische Ammoniumsalze von anionischen Pestiziden
US12098138B2 (en) 2018-05-25 2024-09-24 The Board Of Regents Of The University Of Texas System Substituted pyridinyl azetidinone derivatives for use in treating cancer and other diseases
CN112587481B (zh) * 2020-12-28 2022-03-15 成都中牧生物药业有限公司 一种弱碱性阿莫西林可溶性粉及其制备方法
CN114917223B (zh) * 2022-06-02 2023-10-27 成都倍特药业股份有限公司 一种注射用苯唑西林钠药物组合物及其制备方法
US12409168B2 (en) * 2023-08-17 2025-09-09 Veterinary Pharmacy Corporation Formulations of aminopenicillin and methods for solubilizing aminopenicillin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1466857A (en) 1973-07-12 1977-03-09 Beecham Group Ltd Urea tablets
US4036968A (en) * 1973-07-12 1977-07-19 Beecham Group Limited Pharmaceutical tablet
US4248780A (en) * 1979-08-21 1981-02-03 Canada Packers Limited Process for preparing ampicillin
JPH02124822A (ja) 1988-11-02 1990-05-14 Eisai Co Ltd セファロスポリン含有注射用組成物
JP2761005B2 (ja) 1988-11-02 1998-06-04 エーザイ株式会社 セファロスポリン含有注射用組成物
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
EP0953569A1 (en) * 1998-04-29 1999-11-03 Gist-Brocades B.V. Preparation of beta-lactam antibiotics in the presence of urea or amide
GB0313913D0 (en) * 2003-06-16 2003-07-23 Beecham Pharm Pte Ltd New use
EP1491195A1 (en) * 2003-06-16 2004-12-29 Glaxo Group Limited Pharmaceutical formulations comprising amoxicillin and clavulanate

Also Published As

Publication number Publication date
EP2124887A2 (de) 2009-12-02
BRPI0806900A2 (pt) 2014-04-29
WO2008086971A2 (de) 2008-07-24
US20100035856A1 (en) 2010-02-11
WO2008086971A9 (de) 2009-12-03
WO2008086971A3 (de) 2008-09-25
DE102007002924A1 (de) 2008-07-24

Similar Documents

Publication Publication Date Title
MX2009007384A (es) Formulaciones que contienen ?-lactama con elevada estabilidad en disolucion acuosa.
WO2010078324A3 (en) Companion animal compositions including lipoic acid and methods of use thereof
AP2414A (en) Fungicidal aqueous compositions for seed treatment.
MY155418A (en) Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
WO2012149549A3 (en) Bacillus bacteria for use in treating and preventing infection in aquatic animals
WO2009026166A3 (en) Antiinfective flavonol compounds and methods of use thereof
WO2012033789A3 (en) Treatment of diseases
RU2012157473A (ru) Способ выявления или лечения реакции "трансплантат против хозяина"
WO2009023710A3 (en) Xanthohumol-enriched hop extract
WO2008133894A3 (en) Application of glycerin for improved livestock production
EP2131849A4 (en) COMPOSITIONS AND METHODS OF DISTRIBUTING AGENTS AGAINST CANCER
EP2110128A4 (en) USE OF PARTICULATE ANTIBACTERIAL COMPOUNDS FROM ALLIACEAE AS NATURAL ADDITIVES FOR ANIMAL FEED
WO2010074936A3 (en) Enzastaurin for the treatment of cancer
WO2013067545A3 (en) Compositions and methods for eradication of odors
WO2008087562A3 (en) Methods and compositions for modulating the mirna pathway
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
WO2009011910A3 (en) Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment
TW200740987A (en) Cleaning solutions including preservative compounds for post CMP cleaning processes
UA102376C2 (ru) Стойкая жидкая фармацевтическая композиция на основе тразодона
WO2011038321A3 (en) Compositions of dibromomalonamide and their use as biocides
BRPI0520510A2 (pt) composições antimicrobiais e seus processos associados
MX367167B (es) Composiciones de dibromomalonamida y su uso como biocidas.
WO2008001368A3 (en) Use of stilbene derivatives for treatment and prevention of aquatic mold infections
NZ599151A (en) Pharmaceutical composition comprising radezolid or salt thereof and uses thereof